These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23952897)

  • 1. Community-based treatment for opioid dependent offenders: a pilot study.
    Brown R; Gassman M; Hetzel S; Berger L
    Am J Addict; 2013; 22(5):500-2. PubMed ID: 23952897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom.
    Hickman M; Steer C; Tilling K; Lim AG; Marsden J; Millar T; Strang J; Telfer M; Vickerman P; Macleod J
    Addiction; 2018 Aug; 113(8):1461-1476. PubMed ID: 29672985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising opioid substitution therapy in the prison environment.
    Alam F; Wright N; Roberts P; Dhadley S; Townley J; Webster R
    Int J Prison Health; 2019 Dec; 15(4):293-307. PubMed ID: 31532339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Past-year gambling behaviour among patients receiving opioid substitution treatment.
    Castrén S; Salonen AH; Alho H; Lahti T; Simojoki K
    Subst Abuse Treat Prev Policy; 2015 Jan; 10():4. PubMed ID: 25626451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.
    Richert T; Johnson B
    Harm Reduct J; 2015 Feb; 12():1. PubMed ID: 25889208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention in Georgia opioid substitution therapy program and associated factors.
    Ruadze E; Todadze K
    Harm Reduct J; 2016 Dec; 13(1):35. PubMed ID: 27931232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
    Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
    Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous Australians.
    Gisev N; Gibson A; Larney S; Kimber J; Williams M; Clifford A; Doyle M; Burns L; Butler T; Weatherburn DJ; Degenhardt L
    BMC Public Health; 2014 Sep; 14():920. PubMed ID: 25192713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
    Otiashvili D; Piralishvili G; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    Drug Alcohol Depend; 2013 Dec; 133(2):376-82. PubMed ID: 23916321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on Holland et al. (2014): Opioid maintenance treatment--how much supervision is helpful?
    Koller G
    Addiction; 2014 Apr; 109(4):608-9. PubMed ID: 24605959
    [No Abstract]   [Full Text] [Related]  

  • 12. Opioid substitution therapy: Lowering the treatment thresholds.
    Kourounis G; Richards BD; Kyprianou E; Symeonidou E; Malliori MM; Samartzis L
    Drug Alcohol Depend; 2016 Apr; 161():1-8. PubMed ID: 26832931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients.
    Larance B; Degenhardt L; O'Brien S; Lintzeris N; Winstock A; Mattick RP; Bell J; Ali R
    Drug Alcohol Rev; 2011 Nov; 30(6):613-20. PubMed ID: 21355939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision.
    Clark CB; Hendricks PS; Lane PS; Trent L; Cropsey KL
    Addict Behav; 2014 Dec; 39(12):1736-40. PubMed ID: 25117851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uzbekistan: government discontinues pilot opiate substitution therapy program.
    Khachatrian A
    HIV AIDS Policy Law Rev; 2009 Dec; 14(2):26-7. PubMed ID: 20225509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrests.
    Schwartz RP; Kelly SM; Mitchell SG; Gryczynski J; O'Grady KE; Jaffe JH
    J Subst Abuse Treat; 2019 Feb; 97():7-13. PubMed ID: 30577902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa.
    Goeieman DS; Nonyane DS; Nzaumvila DK; Anse van Rensburg MNS
    Afr J Prim Health Care Fam Med; 2023 Jan; 15(1):e1-e10. PubMed ID: 36744456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversion of methadone and buprenorphine from opioid substitution treatment: a staff perspective.
    Johnson B; Richert T
    J Psychoactive Drugs; 2014; 46(5):427-35. PubMed ID: 25364995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.